A segmented 32P source Monte Carlo model to derive AAPM TG-60 dosimetric parameters used for intravascular brachytherapy

Medical Physics

Volumn 31, Issue 3, 2004, Pages 602-608

  Mourtada, Firas ^a   Soares, Christopher G ^b   Horton, John L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

Author keywords

32P; Beta dosimetry; Intravascular brachytherapy; Monte Carlo simulation

Indexed keywords

ANISOTROPY; DOSIMETRY; ONCOLOGY; RADIOTHERAPY;

DOSE DISTRIBUTIONS; DOSIMETRIC PARAMETER; INTRAVASCULAR BRACHYTHERAPY; MONTE CARLO MODEL; POLAR COORDINATE SYSTEMS; RADIAL DOSE FUNCTION; SOURCE MODELING; ^32P;

MONTE CARLO METHODS;

PHOSPHORUS 32; TUNGSTEN; WATER; PHOSPHORUS;

ANISOTROPY; ARTICLE; AUTOMATION; BETA RADIATION; BRACHYTHERAPY; DOSIMETRY; MONTE CARLO METHOD; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; TREATMENT PLANNING; COMPUTER ASSISTED RADIOTHERAPY; HUMAN; METHODOLOGY; RADIATION DOSE; RADIOMETRY; STANDARD;

ANISOTROPY; BRACHYTHERAPY; HUMANS; MONTE CARLO METHOD; PHOSPHORUS RADIOISOTOPES; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 1642332960     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1646651     Document Type: Article

References (13)

1. R. Waksman, "Vascular brachytherapy: Update on clinical trials," J. Invasive Cardiol. 12, 18A-28A (2000).
2. R. Waksman et al., "Beta radiation delivered via an automatic stepping device to inhibit recurrence of diffuse in-stent restenosis: Clinical and angiographic results of the multicenter GALILEO INHIBIT clinical study," Circulation 104, II-509 (2001).
3. R. Nath et al., "Intravascular brachytherapy physics: Report of the AAPM Radiation Therapy Committee Task Group No. 60," Med. Phys. 26, 119-152 (1999).
4. R. Nath et al., "Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine," Med. Phys. 22, 209-234 (1995).
5. D. R. Schaart, M. C. Clarijs, and A. J. Bos, "On the applicability of the AAPM TG-60/TG-43 dose calculation formalism to intravascular line sources: proposal for an adapted formalism," Med. Phys. 28, 638-653 (2001).
6. N. S. Patel et al., "The use of cylindrical coordinates for treatment planning parameters of an elongated 192Ir source," Int. J. Radiat. Oncol., Biol., Phys. 51, 1093-1102 (2001).
7. L. S. Waters, "MCNPx-User's Manual Version 2.4.0," Los Alamos National Laboratory, Los Alamos, NM, 2002.
8. F. Mourtada et al., "Dosimetry characterization for 32P source wire used for intravascular brachytherapy with automated stepping," Med. Phys. 30, 959-971 (2003).
9. N. B. Grove and M. J. Martin, "Log-f tables for beta decay," Nucl. Data Tables 10, 205 (1971).
10. J. S. Hendricks et al., "Present and future capabilities of MCNP," Appl. Radiat. Isot. 53, 857-861 (2000).
11. D. R. Schaart et al., "A comparison of MCNP4C electron transport with ITS 3.0 and experiment at incident energies between 100 keV and 20 MeV: influence of voxel size, substeps and energy indexing algorithm," Phys. Med. Biol. 47, 1459-1484 (2002).
12. R. Jeraj, P. J. Keall, and P. M. Ostwald, "Comparisons between MCNP, EGS4 and experiment for clinical electron beams," Phys. Med. Biol. 44, 705-717 (1999).
13. P. Karaiskos et al., "Limitations of the point and line source approximations for the determination of geometry factors around brachytherapy sources," Med. Phys. 27, 124-128 (2000).